BioSig Technologies Announces Advanced Research Program with Mayo Clinic

Minneapolis, MN, March 28, 2016 — BioSig Technologies, Inc. (OTCQB: BSGM) today announced the establishment of an advanced research program with Dr. Samuel Asirvatham at Mayo Clinic in Rochester, Minnesota. This program has been designed to build upon the initial studies conducted at Mayo Clinic in March, June and November 2015 through a tripling of investment to …